Parental stress may help explain the link between disease burden and lower self-esteem in children and adolescents with POMS.

Reduced immune responses to the Epstein-Barr virus may help explain the efficacy of anti-CD20 therapy in people with MS, per ...

A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than ...

The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved ...

A fast-track diagnostic pathway that includes a specific MRI marker helped cut the average time to diagnose MS by about half, ...

Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.

Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data ...

The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to ...

Having MS results in columnist Desiree Lama waging a sometimes silent battle against pain, but she's learning to listen to ...

Quantum is working with Thermo Fisher to prepare a Phase 2 trial of Lucid-MS in progressive MS after FDA clearance.

A personalized neuropsychological rehab program may help people with MS manage cognitive issues, according to a feasibility ...